Urology · Brownstown Twp, MI
NPI
1760475131
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
19117 Allen Rd Ste A
Brownstown Twp, MI, 48183
Phone (734) 676-4040
Groups this clinician bills Medicare through
Medicare paid, 2024
$337K
10,021 services
Medicare patients, 2024
786
Average age 75
Drug cost, 2024
$3.6M
4,868 prescriptions
Company payments, 2025
$2,233
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David W Law was code 81003 (clinical chemistry), 968 times for 600 patients. In total David W Law billed 10,021 services in 109 codes, and Medicare paid $337K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 968 | 600 | $2.19 | $2,119 |
| 99214 Office E&M - Established | Office | 873 | 584 | $89.70 | $78K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 652 | 500 | $12.26 | $7,990 |
| 51798 Ultrasound - Nonspecific | Office | 333 | 216 | $8.49 | $2,826 |
| 84153 Clinical Chemistry | Office | 299 | 239 | $18.02 | $5,388 |
| 80048 Clinical Chemistry | Office | 294 | 255 | $8.29 | $2,437 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 272 | 58 | $48.78 | $13K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 171 | 19 | $139.71 | $24K |
| 96372 Injection Administration | Office | 102 | 23 | $10.64 | $1,085 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 93 | 47 | $31.01 | $2,884 |
| 99204 Office E&M - New | Office | 88 | 88 | $122.85 | $11K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 79 | 41 | $38.01 | $3,003 |
| 52000 Cystourethroscopy | Office | 73 | 65 | $182.73 | $13K |
| 51705 Other Organ Systems | Office | 63 | 11 | $78.30 | $4,933 |
| 80076 Clinical Chemistry | Office | 62 | 33 | $8.01 | $497 |
By year: 2022 $320K for 10,423 services; 2023 $239K for 6,728 services; 2024 $337K for 10,021 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 968 | 600 | $2.19 | $2,119 |
| 84153 Clinical Chemistry | 299 | 239 | $18.02 | $5,388 |
| 80048 Clinical Chemistry | 294 | 255 | $8.29 | $2,437 |
| 80076 Clinical Chemistry | 62 | 33 | $8.01 | $497 |
| 84403 Clinical Chemistry | 53 | 25 | $25.29 | $1,340 |
| 84100 Clinical Chemistry | 49 | 22 | $4.65 | $228 |
| 83735 Clinical Chemistry | 47 | 20 | $6.57 | $309 |
| 85025 Blood Count | 40 | 27 | $7.61 | $304 |
| 36415 Venipuncture Blood Collection | 16 | 16 | $8.65 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug David W Law prescribed most often to Medicare patients was Finasteride, with 1,074 prescriptions and refills. In total David W Law wrote 4,868 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 1,074 | 2,945 | 336 | $20K |
| Tamsulosin Hcl Generic | 788 | 2,053 | 295 | $14K |
| Cephalexin Generic | 404 | 486 | 128 | $3,348 |
| Ciprofloxacin Hcl Generic | 363 | 363 | 280 | $787 |
| Dutasteride Generic | 270 | 759 | 77 | $9,095 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 191 | 426 | 67 | $13K |
| Xtandi Enzalutamide | 191 | 191 | 24 | $2.6M |
| Oxybutynin Chloride Er Oxybutynin Chloride | 151 | 362 | 50 | $3,677 |
| Myrbetriq Mirabegron | 125 | 281 | 56 | $119K |
| Desmopressin Acetate Generic | 110 | 263 | 32 | $9,949 |
| Allopurinol Generic | 83 | 242 | 31 | $1,119 |
| Orgovyx Relugolix | 82 | 82 | 14 | $216K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 72 | 193 | 31 | $2,476 |
| Gemtesa Vibegron | 64 | 96 | 15 | $44K |
| Tolterodine Tartrate Er Tolterodine Tartrate | 64 | 170 | 24 | $6,884 |
Brand drugs: - claims; generic drugs: 4,295 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David W Law $2,233 ($2,233 in general payments such as food, travel and fees) from 30 companies. The largest payer was Janssen Biotech, Inc. with $231.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 12 | $231 |
| Sumitomo Pharma America, Inc. 4506.T | 13 | $204 |
| Biotissue Holdings Inc. | 1 | $158 |
| Verity Pharmaceuticals Inc. | 7 | $157 |
| Pfizer Inc. PFE | 6 | $146 |
| Tolmar, Inc. | 7 | $122 |
| Astellas Pharma US Inc 4503.T | 5 | $119 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $110 |
| Antares Pharma, Inc. | 5 | $89.72 |
| Teleflex LLC TFX | 4 | $88.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.